Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04358237
Title Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. (LUPER)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Antonio Calles Blanco

lung small cell carcinoma


Lurbinectedin + Pembrolizumab

Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.